HOMAGEB78CERTIFIED
High confidenceUp to 70% total LTV

267 Broadway

Development SiteSale$30.0M

This is a clean land acquisition by a credible, repeat sponsor — The Rabsky Group — in a highly active development corridor along lower Broadway in Manhattan, proximate to the Financial District, Tribeca, and City Hall. The $579 PPSF is consistent with comparable development site transactions in this submarket, supported by the 10 comps listed, and reflects reasonable market pricing for a site of this scale. No distress indicators, liens, litigation, or foreclosure flags are present, and the JLL brokerage team represents institutional-quality deal execution. The primary risk factors are execution risk on ground-up development in a still-recovering Manhattan office and residential market, and the absence of disclosed financing terms, which limits underwriting visibility on leverage. Overall, this is a solid land acquisition with a known buyer, clean title signals, and credible submarket demand drivers.

Deal Stats

Asset TypeDevelopment Site
Transaction TypeSale
Amount$30.0M
Total SF51,730 SF
Price / SF$579/SF
Deal DateMay 13, 2026
AI ConfidenceHigh
Track Record Score85/100
AI Deal Typesale
Deal InfoThe asset involved in the transaction is a development site located at 267 Broadway in Manhattan. The property was sold for $30,000,000, encompassing a total area of 51,730 square feet, which translates to a price per square foot of $579.

Parties

Seller / Landlord

Braha Industries & Roe Corporation

Braha Industries and Roe Corporation are established NYC real estate entities with long-standing holdings in Manhattan's lower Broadway corridor; Braha Industries in particular has been a known landowner and developer in the Downtown Manhattan and Tribeca markets for decades.

Buyer / Tenant

The Rabsky Group ()

The Rabsky Group is a prominent Brooklyn-based developer with a strong track record of large-scale residential and mixed-use development projects across NYC, including significant activity in Downtown Brooklyn, Williamsburg, and Manhattan. They are known as an experienced, well-capitalized sponsor with a history of executing complex ground-up development projects.

Score Analysis

What this score means

A Grade B score indicates this deal qualifies for financing at up to 70% LTV, subject to full underwriting. Most deals at this level proceed to a term sheet within 2 business days.

Why this score

Sponsor Track Record

The Rabsky Group's proven execution on large-scale residential and mixed-use projects across multiple NYC submarkets demonstrates capital availability and development competency.

Submarket Fundamentals

Lower Broadway's proximity to Financial District, Tribeca, and City Hall provides strong underlying demand for residential and mixed-use development.

Valuation Support

The $579/SF pricing is validated by 10 comparable transactions, indicating fair market value with no premium overpayment.

Development Execution Risk

Ground-up development in Manhattan's recovering office and residential market presents timing, leasing, and market absorption uncertainties.

Financing Visibility Gap

Undisclosed leverage terms limit assessment of sponsor liquidity reserves and debt service capacity through market downturns.

How to improve

The following actions could meaningfully improve this deal's Homage score. Each suggestion is based on the deal's profile, asset type, and current rating — addressing them before approaching a lender can increase approval likelihood and lower borrowing costs.

Disclose Loan Terms

Publication of LTV, interest rate, and debt service coverage ratio assumptions would validate sponsor financial strength and project economics.

+8-12 points

Market Study & Leasing Strategy

Pre-development market absorption analysis and preliminary leasing or sales strategy would quantify residential/commercial demand and de-risk execution.

+6-10 points

Zoning & Entitlement Status

Explicit confirmation of zoning compliance, remaining entitlement pathway, and estimated timeline to building permit would reduce regulatory execution risk.

+5-8 points

Similar Deals

See all